(Reuters) – Alphabet Inc.'s life sciences division is indeed partnering with reinsurance company Swiss Re to launch a unit to provide stop loss insurance, a financial product purchased by employers to cover the health care costs of unexpected and large employees.  The subsidiary, Coefficient Insurance Co., will be supported by the commercial insurance group Swiss Re, which is also making a minority investment in the new company, Verily said on Tuesday.
"The coefficient aims to reduce blind spots and provide greater cost control mechanisms for self-financed employers," CEO Andy Conrad said in a statement.
Indeed, formerly part of Google's research and development unit, has been linked to several pharmaceutical companies on projects such as It ranges from research on surgical robots to the development of retinal scanning technology for early detection. of certain eye diseases.